<DOC>
	<DOCNO>NCT01618695</DOCNO>
	<brief_summary>The purpose study confirm efficacy safety perampanel compare placebo patient refractory partial-onset seizure</brief_summary>
	<brief_title>A Study With Open-label Extension Phase Evaluate Efficacy Safety Perampanel ( E2007 ) Administered Adjunctive Therapy Subjects With Refractory Partial-onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<criteria>Inclusion Criteria 1 . Male female great equal 12 year age ; 2 . Have diagnosis epilepsy partial seizure without secondarily generalize seizures 3 . Subjects compute tomography ( CT ) magnetic resonance imaging ( MRI ) diagnosis 4 . Subjects treat least 12 week confirm uncontrolled one standard AED 2 year enrollment 5 . During 6week Prerandomization Phase subject must great equal 5 partial seizure per 6week 6 . Are stable dose administration concomitant AED ( ) 1 month prior Visit 1 Exclusion Criteria 1 . Presence nonmotor simple partial seizure ; 2 . Presence primary generalize epilepsy seizure , absence and/or myoclonic epilepsy ; 3 . Presence previous history LennoxGastaut syndrome ; 4 . A history status epilepticus within 1 year enrollment Prerandomization Phase 5 . Seizure cluster individual seizure count 6 . A history psychogenic seizure within 5 year enrollment Prerandomization Phase</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Partial-onset Seizures</keyword>
	<keyword>partial seizure</keyword>
	<keyword>seizure</keyword>
	<keyword>epilepsy</keyword>
</DOC>